Sort
48,018 grants matching “immunotherapy”
Synthesis of Glycopeptide-Based Cancer Antigen Vaccines
$420,836Katherine A Wall · University Of Toledo Health Sci Campus · R15 · FY2015 · GM
Role of immune cell OGR1 in prostate cancer development and the mechanisms involv
$420,784Yan Xu · Indiana University Indianapolis · R01 · FY2012 · CA
Circulating Tumor Cells Analyses and Molecular Profiling for Patients Receiving Radiation Therapy
$420,763Gary D Kao · University Of Pennsylvania · R01 · FY2019 · CA
Interactions between the tumor cells and the neuro-immune microenvironment in mutant IDH1 gliomas: implications for therapeutics
$420,701Maria G Castro · University Of Michigan At Ann Arbor · R01 · FY2020 · NS
Ablating Liver Metastases with SBRT to Enhance Immune Checkpoint Blockade in Melanoma
$420,670Theodore S Lawrence · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Platelet Serine/Threonine Phosphatases in Cancer Pathophysiology
$420,583K. Vinod Vijayan · Baylor College Of Medicine · R01 · FY2025 · CA
Phase IbTrial of Rintatolimod and IFNa Regimen in Cancer Patients with Mild or Moderate COVID-19 infection
$420,500Candace S Johnson · Roswell Park Cancer Institute Corp · P30 · FY2020 · CA
Immunoengineered nanotechnology for targeted expansion of regulatory T cells
$420,417Jamie Berta Spangler · Johns Hopkins University · R01 · FY2022 · EB
Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy
$420,407Yevgeniy Vinogradskiy · Thomas Jefferson University · UH3 · FY2025 · CA
IMMUNOTHERAPEUTIC AGENTS TO TREAT ALZHEIMER'S DISEASE
$420,400Boston Biomedical Research Institute · R01 · FY2004 · AG
IMMUNOTHERAPEUTIC AGENTS TO TREAT ALZHEIMER'S DISEASE
$420,400Boston Biomedical Research Institute · R01 · FY2003 · AG
IMMUNOTHERAPEUTIC AGENTS TO TREAT ALZHEIMER'S DISEASE
$420,400Boston Biomedical Research Institute · R01 · FY2002 · AG
ONCOLYTIC IMMUNOTHERAPY FOR DIFFUSE INTRINSIC PONTINE GLIOMAS
$420,362The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2017 · Department of the Army
Cassette exons in neoplastic pro-B-cells: implications for immunotherapy
$420,362Andrei Thomas-Tikhonenko · Children'S Hosp Of Philadelphia · U01 · FY2022 · CA
Nurse Practitioner Use of Telehealth for Transplant Care
$420,330University Of Tennessee Health Sci Ctr · R01 · FY2004 · NR
Harnessing the therapeutic potential of histotripsy focused ultrasound-induced immunogenic cancer cell death
$420,313Clifford Cho · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
CLINICAL THERAPY TRIALS
$420,296Katherine Kurshan Matthay · Children'S Hospital Of Los Angeles · P01 · FY2011 · CA
Immunobiology of Myeloid and Lymphoid Cells
$420,243Dartmouth College · T32 · FY2003 · AI
Augmenting Antitumor Immunity
$420,228Hyam Isaac Levitsky · Johns Hopkins University · P01 · FY2012 · CA
Bioinformatics Technology to Characterize Tumor Infiltrating Immune Repertoires
$420,221Xiaole Shirley Liu · Dana-Farber Cancer Inst · U01 · FY2019 · CA
Preventing follicular lymphoma progression and transformation through precision therapy
$420,219Wendy Beguelin · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Developmental Funds
$420,175Edward Chu · Albert Einstein College Of Medicine · P30 · FY2023 · CA
Molecular dissecting and targeting YAP1 mediated cancer stemness and immune suppression in advanced gastric adenocarcinoma
$420,169Shumei Song · Coriell Institute For Medical Research · R01 · FY2024 · CA
Host Immunoregulation of Response to Antileishmanial Chemotherapy
$420,128Henry W. Murray · Weill Medical Coll Of Cornell Univ · R56 · FY2007 · AI
Identifying therapeutic pathways targeting medulloblastoma-immune cell interactions
$420,114Ernest Fraenkel · Massachusetts Institute Of Technology · U01 · FY2025 · CA